drugset / Trial / NCT01292252
Use of Forteo (Teriparatide) in Posterolateral Lumbar Spine Fusion
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine the effects of 12 weeks of daily treatment with teriparatide on spine fusion in adult patients who are undergoing multi-level posterolateral spine fusion surgery for degenerative conditions of the lumbar spine.
Timeline
- Start
- 2011-08
- Primary completion
- 2015-12
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Teriparatide | Protein / enzyme biologic | 20 ug | Subcutaneous |